Publications
đź“… 2025
Pharmacogenomic Drug–Target Network Analysis Reveals Similarity Profiles Among FDA–Approved Cancer Drugs
Authors: Alberto Berral-González, Monica M Arroyo, Diego Alonso-LĂłpez, MarĂa JesĂşs Rivas-LĂłpez, JosĂ© Manuel Sánchez-Santos, Javier De Las RivasJournal: Pharmaceutics, Vol. 17, NĂşm. 11, p. 1421.
RAS–p110α signalling in macrophages is required for effective inflammatory response and resolution of inflammation
Authors: Alejandro Rosell, Agata Adelajda Krygowska, Marta AlcĂłn PĂ©rez, Cristina Cuesta, Mathieu-Benoit Voisin, Juan de Paz, HĂ©ctor Sanz-Fraile, Vinothini Rajeeve, Ana Carreras-González, Alberto Berral-González, Ottilie Swinyard, Enrique GabandĂ©-RodrĂguez, Julian Downward, Jordi Alcaraz, Juan Anguita, Carmen GarcĂa-MacĂas, Javier De Las Rivas, Pedro R Cutillas, Esther Castellano SanchezJournal: eLife, 13:RP94590.
Novel Assignment of Gene Markers to Hematological and Immune Cells Based on Single-Cell Transcriptomics
Authors: De La Rosa, Enrique; Alonso-Moreda, Natalia; Berral-González, Alberto; Sánchez-Luis, Elena; González-Velasco, Oscar; Sánchez-Santos, José Manuel; De Las Rivas, Javier.Journal: International Journal of Molecular Sciences, Vol. 26, Núm. 2, p. 805.
đź“… 2024
Stratification of colorectal patients based on survival analysis shows the value of consensus molecular subtypes and reveals the CBLL1 gene as a biomarker of CMS2 tumours
Authors: AlfonsĂn, Gloria; Berral-González, Alberto; RodrĂguez-Alonso, Andrea; Quiroga, Macarena; De Las Rivas, Javier; Figueroa, AngĂ©lica.Journal: International Journal of Molecular Sciences, Vol. 25, NĂşm. 3, p. 1919.
RAS-p110α signalling in macrophages is required for effective inflammatory response and resolution of inflammation
Authors: Rosell, Alejandro; Krygowska, Agata A.; Pérez, Marta Alcón; Voisin, Mathieu-Benoit; de Paz, Juan; Sanz-Fraile, Héctor; Rajeeve, Vinothini; Berral-González, Alberto; Cuesta, Cristina; Swinyard, Ottilie, et al.Journal: eLife, Vol. 13.
Cross-species regulatory network analysis identifies FOXO1 as a driver of ovarian follicular recruitment
Authors: Kramer, Ashley E.; Berral-González, Alberto; Ellwood, Kathryn M.; Ding, Shanshan; De Las Rivas, Javier; Dutta, Aditya.Journal: Scientific Reports, Vol. 14, Núm. 1, p. 30787.
đź“… 2023
Identification of a gene expression signature associated with breast cancer survival and risk that improves clinical genomic platforms
Authors: Bueno-Fortes, Santiago; Berral-González, Alberto; Sánchez-Santos, José Manuel; Martin-Merino, Manuel; De Las Rivas, Javier.Journal: Bioinformatics Advances, Vol. 3, Núm. 1, p. vbad037.
Comparative analysis of cell mixtures deconvolution and gene signatures generated for blood, immune and cancer cells
Authors: Alonso-Moreda, Natalia; Berral-González, Alberto; De La Rosa, Enrique; González-Velasco, Oscar; Sánchez-Santos, José Manuel; De Las Rivas, Javier.Journal: International Journal of Molecular Sciences, Vol. 24, Núm. 13, p. 10765.
RAS-PI3K signaling: a master regulator of CAF phenotype to promote lung tumor progression
Authors: Rosell, Alejandro; Cuesta, Cristina; Berral-González, Alberto; MartĂnez, BelĂ©n; Hynds, Robert E.; Swanton, Charles; De Las Rivas, Javier; Castellano, Esther.
RAS signalling beyond cancer cells: controlling the physicochemical properties of the extracellular matrix to impact tumour progression
Authors: Cuesta, Cristina; Rosell, Alejandro; Berral-González, Alberto; MartĂnez, BelĂ©n; Hynds, Robert E.; Swanton, Charles; De Las Rivas, Javier; Castellano, Esther.đź“… 2022
Expression profiles of HCT116 colorectal cancer cells and HCT116-derived CDKN1A (p21) knockout (ko) cells (Dataset)
Authors: Bueno-Fortes, Santiago; Muenzner, Julienne K.; Berral-González, Alberto; Hampel, Chuanpit; Lindner, Pablo; Berninger, Alexandra; Huebner, Kerstin; Kunze, Philipp; Bäuerle, Tobias; Erlenbach-Wuensch, Katharina, et al.Published: GEO-Gene Expression Omnibus.
đź“… 2021
Cancer-associated fibroblast-derived gene signatures determine prognosis in colon cancer patients
Authors: Herrera, Mercedes; Berral-González, Alberto; LĂłpez-Cade, Igor; Galindo-Pumariño, Cristina; Bueno-Fortes, Santiago; MartĂn-Merino, Manuel; Carrato, Alfredo; Ocaña, Alberto; De La Pinta, Carolina; LĂłpez-Alfonso, Ana, et al.Journal: Molecular Cancer, Vol. 20, NĂşm. 1, p. 73.
Bipartite networks of cancer genes associated with specific drugs using pharmacogenomics
Authors: Alberto Berral-González; Monica M. Arroyo; Diego Alonso-Lopez; Santiago Bueno-Fortes; Javier De Las Rivas.Journal: F1000 Research.
A gene signature derived from the loss of CDKN1A (p21) is associated with CMS4 colorectal cancer
Authors: Bueno-Fortes, Santiago; Muenzner, Julienne K.; Berral-González, Alberto; Hampel, Chuanpit; Lindner, Pablo; Berninger, Alexandra; Huebner, Kerstin; Kunze, Philipp; Bäuerle, Tobias; Erlenbach-Wuensch, Katharina, et al.Journal: Cancers, Vol. 14, Núm. 1, p. 136.
đź“… 2020
Mining drug-target associations in cancer: analysis of gene expression and drug activity correlations
Authors: Arroyo, Monica M.; Berral-González, Alberto; Bueno-Fortes, Santiago; Alonso-López, Diego; De Las Rivas, Javier.Journal: Biomolecules, Vol. 10, Núm. 5, p. 667.
đź“… 2019
OMICfpp: a fuzzy approach for paired RNA-Seq counts
Authors: Berral-González, Alberto; Riffo-Campos, Angela L.; Ayala, Guillermo.Journal: BMC Genomics, Vol. 20, p. 1-20.